Table 2.
Toxic effects of TiO2 NPs on CNS in in vivo studies
| Crystal type | Animals | Cell type | Parameters/dose | Main findings | Reference |
|---|---|---|---|---|---|
| Rutile 80 nm anatase 155 nm | CD-1 (ICR) female mice | Nasal instillation | 500 μg; every other day for 30 days | Ti contents detected in the brain; GFAP-positive cell, CAT, SOD, MDA, protein carbonyls, AChE activities, glutamic acid, and NO increased | [25] |
| Anatase bulk | CD-1 (ICR) female mice | Delivered to the abdominal cavity | 5 nm; 5, 10, 50, 100, 150 mg/kg BW; every day for 14 days | Ti contents detected in brain; O2, H2O2, MDA, NOS, NO increased; Glu contents, antioxidative enzymes, non-enzymatic antioxidant contents, and AChE activity decreased | [79] |
| Anatase | CD-1 male mice | Intranasal administration | 5–6 nm; 2. 5, 5, 10 mg/kg BW. every day for 90 days | Ti contents detected in brain; no daily behavioral changes; O2, H2O2, MDA, protein carbonyl, 8-OHdg, p38, JNK, NF-κB, Nrf-2, and HO-1 increased | [80] |
| Anatase | Sprague–Dawley rats (male and female) | Subcutaneous injection | 5 nm; 500 μl (1 μg/μl) on GD 6, 9, 12, 15, and 18 | CAT, GSH-PX, and T-AOC decreased; MDA and 8-hydroxydeoxyguanosine (8-OHdG) increased | [72] |
| Rutile 80 nm anatase 155 nm | CD-1 (ICR) female mice | Intranasal instillation | 500 μg; every other day for 30 days; evaluated at 2, 10, 20, and 30 days of post-instillation time points | Ti contents detected in brain; GSH-Px, GST, SOD and GSH not changed; MDA, TNF-α and IL-1β increased | [53] |
| Anatase | CD-1 (ICR) female mice | Intranasal administration | 5–6 nm; 2.5, 5, 10 mg/kg BW; every day for 90 days | TLR2, TLR4, TNF-α, IKK1, IKK2, NF-κB, NF-κBP52, NF-κBP65, NIK, and IL-1β increased; spatial recognition memory and locomotor activity affected | [81] |
| Rutile | Male C57BL/6 mice | Intraperitoneal injection | Fine (<1 μm), ultrafine (21 nm); 40 mg/kg BW; one injection 30 min after LPS or vehicle injection | IL-1β, TNF-α, iNOS, ROS production, and OX-42 enhanced by ultrafine TiO2 in the LPS-stimulated group | [82] |
| Anatase | CD-1 (ICR) female mice | Intragastric administration | 6.5 nm; 5, 10, 50 mg/kg BW; every day for 60 days | Ti contents in the hippocampus increased; caspase-9, caspase-3, Bax, cytochrome c, O2 and H2O2 upregulated; Bcl-2, SOD, CAT, APx, and GSH-Px reduced | [83] |
| Anatase | CD-1 female mice | Nasal administration | 5–6 nm; 2.5, 5, 10 mg/kg BW; every day for 90 days | NR2A, NR2B, CREB-1, CREB-2, FosB/DFosB, CaMKIV, and pCREB decreased | [85] |
| Anatase | CD-1 female mice | Intragastric administration | 5 nm; 5, 10, 50 mg/kg BW; every day for 60 days | Ti contents in brain upregulated; reduction in the activities of Na+/K+-ATPase, Ca2+-ATPase, Ca2+/Mg2+-ATPase; Ache, Glu, and NO elevated; NE, DA, DOPAC, 5-HT, and 5-HIAA reduced | [86] |
| Anatase | Pregnant ICR mice | Subcutaneous injection | 2570 nm; 100 μg, injection on GD 6, 9, 12, 15 | Genes related with cell death, apoptosis, oxidative stress, inflammation and neurotransmitters changed | [70] |
| Rutile | Pregnant BALB/c mice | Intravenous injection | 35 nm; 0.8 mg, injections on GD 16 and 17 | Lower uterine weights and smaller fetuses; fetal resorption and retarded fetal growth | [67] |
| Anatase | Pregnant Wistar rats | Intragastric administration | 10 nm; 100 mg/kg BW, every day from GD 2 to 21 | Ti contents elevated and Ki-67-positive cells reduced; learning and memory in offspring disrupted | [66] |